Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04677634 · ClinicalTrials.gov registry record · NA

Open Label Tolerability Study of ISOThrive Prebiotic Nectar (MIMO) in Subjects With Constipation

A NA study of Constipation, sponsored by ISOThrive.

Completed
Registry status
NA
Development phase
106
Enrollment target
1
Study location

NCT04677634 is a NA study of Constipation that has completed, run by ISOThrive. The registered enrollment target is 106 participants, below the 203-participant average among 54 other Constipation trials with a reported enrollment target (48% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04677634, a NA study of Constipation, has completed, sponsored by ISOThrive.

COMPLETED
Registry status
NA
Development phase
106 participants
Enrollment target
1
Study location

Study Summary

The purpose and efficacy endpoint of this study is to assess whether subjects with constipation predominant irritable bowel syndrome (IBS-C) or chronic Idiopathic constipation (CIC) tolerate ISOThrive.

Conditions Studied

Constipation

Interventions

  • DIETARY_SUPPLEMENT ISOThrive Prebiotic Nectar

Study Locations (1)

Virginia

  • ISOThrive Inc. - Manassas

Trial Details

FieldValue
Enrollment Target 106 participants
Start Date 2020-10-14
Est. Completion 2021-04-02
Phase NA

Sponsor

ISOThrive

2 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT04677634

The ClinicalTrials.gov registry entry for NCT04677634 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 106 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 203-participant average among 54 other Constipation trials with a reported enrollment target (48% lower). The listed sponsor is ISOThrive, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Constipation appearing as the primary indexed condition, and to 1 intervention - of which ISOThrive Prebiotic Nectar is the first listed.

NCT04677634 reports 1 study location spanning 1 distinct geographic area - top geographies include Virginia.

Frequently Asked Questions

What is clinical trial NCT04677634 about?

NCT04677634 is a clinical study titled "Open Label Tolerability Study of ISOThrive Prebiotic Nectar (MIMO) in Subjects With Constipation". The purpose and efficacy endpoint of this study is to assess whether subjects with constipation predominant irritable bowel syndrome (IBS-C) or chronic Idiopathic constipation (CIC) tolerate ISOThrive.

What is the current status of trial NCT04677634?

This trial is currently completed. It is a NA study. The enrollment target is 106 participants. The study started on 2020-10-14. Estimated completion is 2021-04-02.

What conditions does trial NCT04677634 study?

This clinical trial studies the following conditions: Constipation.

What interventions are being tested in trial NCT04677634?

The interventions under investigation include: ISOThrive Prebiotic Nectar (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT04677634?

This trial is sponsored by ISOThrive, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04677634 being conducted?

This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Constipation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Constipation

All registered trials for this condition

Virginia

All trials with a study site in Virginia

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.